Perspectives in drug therapy of HIV infection (Q34300207)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Perspectives in drug therapy of HIV infection	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7614897

retrieved

1 August 2017

title

Perspectives in drug therapy of HIV infection (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7614897

retrieved

1 August 2017

author name string

Darbyshire J

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7614897

retrieved

1 August 2017

publication date

1 January 1995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7614897

retrieved

1 August 2017

published in

Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7614897

retrieved

1 August 2017

volume

49 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7614897

retrieved

1 August 2017

page(s)

1-3; discussion 38-40

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7614897

retrieved

1 August 2017

cites work

Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7614897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7614897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7614897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7614897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7614897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PubMed publication ID

7614897

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7614897

retrieved

1 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34300207&oldid=1546480387"